| 319 | | - High: 3a (investigate simple ITK), 5d (browse hubmap datasets) |
| 320 | | - Medium: 1 (general NIAID use cases),3bc (seg web services, reading seg formats), 8a (workshops), 6 (dicom) |
| 321 | | - Low: 5abc (hubmap viz tools, UI clustering, light microscopy analysis), 7 ("hasp" homology modeling pipeline at their website) |
| | 319 | - High: 3a (investigate simple ITK), 5d (browse hubmap datasets, being able to visualize the data conveniently and without long setup) |
| | 320 | - Medium: 1 (general NIAID use cases),3bc (seg web services, reading seg formats), 8a (workshops), 6 (dicom, depends on collaborator) |
| | 321 | - Low: 5abc (additional hubmap viz tools e.g. data overlays like cell type on imaging, UI for clustering, light microscopy analysis), 7 ("hasp" homology modeling pipeline at their website) |
| | 322 | |
| | 323 | TomG: segmentation is diff for diff applications (medical vs. cryoEM, light microscopy, etc.). Where is the emphasis? |
| | 324 | |
| | 325 | Darrell: ITK has focused primarily on medical imaging, but the team is looking into using it on density etc. Would like to bring improvements from molecular viz into medical image analysis and vice versa. Separately, NIH is investing heavily cryoEM and related tools. Our own group's emphasis will segmentation as it applies to cryoEM. |
| | 326 | |
| | 327 | Phil: use VR to view medical images along with their segmentations. |
| | 328 | |
| | 329 | Darrell: Re the modeling pipeline, it's not yet approved, we're not sure it will happen. (Scooter: it can be put under 1, miscellaneous NIAID needs that arise.) |
| | 330 | |